Published in Chem Biol on May 22, 2014
On the lag phase in amyloid fibril formation. Phys Chem Chem Phys (2015) 0.98
A Guide to Structured Illumination TIRF Microscopy at High Speed with Multiple Colors. J Vis Exp (2016) 0.81
β-Amyloid peptides and amyloid plaques in Alzheimer's disease. Neurotherapeutics (2015) 0.80
Molecular probes for fluorescence lifetime imaging. Bioconjug Chem (2015) 0.80
Direct Observation of α-Synuclein Amyloid Aggregates in Endocytic Vesicles of Neuroblastoma Cells. PLoS One (2016) 0.78
Probing amyloid protein aggregation with optical superresolution methods: from the test tube to models of disease. Neurophotonics (2016) 0.77
Fluorescence Self-Quenching from Reporter Dyes Informs on the Structural Properties of Amyloid Clusters Formed in Vitro and in Cells. Nano Lett (2016) 0.75
Selective inhibition of aggregation/fibrillation of bovine serum albumin by osmolytes: Mechanistic and energetics insights. PLoS One (2017) 0.75
Filming protein fibrillogenesis in real time. Sci Rep (2014) 0.75
Endocytic uptake of monomeric amyloid-β peptides is clathrin- and dynamin-independent and results in selective accumulation of Aβ(1-42) compared to Aβ(1-40). Sci Rep (2017) 0.75
Timing protein assembly in neurons. Chem Biol (2014) 0.75
From single-molecule spectroscopy to super-resolution imaging of the neuron: a review. Methods Appl Fluoresc (2016) 0.75
Polarized super-resolution structural imaging inside amyloid fibrils using Thioflavine T. Sci Rep (2017) 0.75
NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
Precise nanometer localization analysis for individual fluorescent probes. Biophys J (2002) 22.24
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun (1984) 20.07
Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A (1985) 16.10
The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry (1993) 7.26
Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron (2005) 6.20
Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci (1991) 5.71
Highly inclined thin illumination enables clear single-molecule imaging in cells. Nat Methods (2008) 5.01
On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci U S A (1996) 4.75
Misfolded proteins partition between two distinct quality control compartments. Nature (2008) 4.75
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem (1992) 4.66
Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener (2007) 4.15
Intraneuronal Abeta42 accumulation in human brain. Am J Pathol (2000) 3.83
The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry (2000) 3.31
Real-time computation of subdiffraction-resolution fluorescence images. J Microsc (2010) 3.07
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A (2013) 2.89
Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci (2004) 2.64
A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol (2010) 2.48
Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc Natl Acad Sci U S A (2009) 2.14
Amyloid-β forms fibrils by nucleated conformational conversion of oligomers. Nat Chem Biol (2011) 2.08
Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc Natl Acad Sci U S A (1992) 1.85
From macroscopic measurements to microscopic mechanisms of protein aggregation. J Mol Biol (2012) 1.71
The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide. Nat Struct Mol Biol (2011) 1.62
Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta. J Mol Biol (1996) 1.45
Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proc Natl Acad Sci U S A (2010) 1.42
Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein. Nat Methods (2007) 1.39
In situ measurements of the formation and morphology of intracellular β-amyloid fibrils by super-resolution fluorescence imaging. J Am Chem Soc (2011) 1.37
Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging. FASEB J (2006) 1.35
Mechanisms of quenching of Alexa fluorophores by natural amino acids. J Am Chem Soc (2010) 1.31
Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A beta 1-42, in differentiated PC12 cells. Brain Res (1997) 1.23
Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons. Brain Res (2007) 1.18
A FRET sensor for non-invasive imaging of amyloid formation in vivo. Chemphyschem (2011) 1.12
Extracellular monomeric tau protein is sufficient to initiate the spread of tau protein pathology. J Biol Chem (2013) 1.07
Direct observation of heterogeneous amyloid fibril growth kinetics via two-color super-resolution microscopy. Nano Lett (2013) 1.02
Protein amyloids develop an intrinsic fluorescence signature during aggregation. Analyst (2013) 0.98
A label-free, quantitative assay of amyloid fibril growth based on intrinsic fluorescence. Chembiochem (2013) 0.95
Acidic pH promotes the formation of toxic fibrils from beta-amyloid peptide. Brain Res (2001) 0.95
High-resolution 3D reconstruction reveals intra-synaptic amyloid fibrils. Am J Pathol (2011) 0.85
Fluorescence lifetime dynamics of enhanced green fluorescent protein in protein aggregates with expanded polyglutamine. J Biomed Opt (2010) 0.80
Selenium-enhanced electron microscopic imaging of different aggregate forms of a segment of the amyloid β peptide in cells. ACS Nano (2012) 0.78
The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol (2014) 2.99
A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers. Nat Struct Mol Biol (2015) 2.53
Getting out of shape. Nature (2002) 1.71
Protein folding and disease: a view from the first Horizon Symposium. Nat Rev Drug Discov (2003) 1.27
Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour. Nat Commun (2014) 1.20
Ostwald's rule of stages governs structural transitions and morphology of dipeptide supramolecular polymers. Nat Commun (2014) 1.01
Chemical kinetics for drug discovery to combat protein aggregation diseases. Trends Pharmacol Sci (2014) 0.99
TestSTORM: Simulator for optimizing sample labeling and image acquisition in localization based super-resolution microscopy. Biomed Opt Express (2014) 0.94
Population of nonnative states of lysozyme variants drives amyloid fibril formation. J Am Chem Soc (2011) 0.93
Antibodies and protein misfolding: From structural research tools to therapeutic strategies. Biochim Biophys Acta (2014) 0.84
Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation. Nat Commun (2016) 0.84
Latent analysis of unmodified biomolecules and their complexes in solution with attomole detection sensitivity. Nat Chem (2015) 0.80
Quantitative thermophoretic study of disease-related protein aggregates. Sci Rep (2016) 0.80
De novo design of a biologically active amyloid. Science (2016) 0.78
β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces. Sci Rep (2016) 0.78
The chaperone HSPB8 reduces the accumulation of truncated TDP-43 species in cells and protects against TDP-43-mediated toxicity. Hum Mol Genet (2016) 0.76
Structural Ensembles of Membrane-bound α-Synuclein Reveal the Molecular Determinants of Synaptic Vesicle Affinity. Sci Rep (2016) 0.76
Silk micrococoons for protein stabilisation and molecular encapsulation. Nat Commun (2017) 0.76
Structure of a single-chain Fv bound to the 17 N-terminal residues of huntingtin provides insights into pathogenic amyloid formation and suppression. J Mol Biol (2015) 0.75
Quantitative analysis of co-oligomer formation by amyloid-beta peptide isoforms. Sci Rep (2016) 0.75
Multi-dimensional super-resolution imaging enables surface hydrophobicity mapping. Nat Commun (2016) 0.75
α-Synuclein - Regulator of Exocytosis, Endocytosis, or Both? Trends Cell Biol (2017) 0.75
The relevance of contact-independent cell-to-cell transfer of TDP-43 and SOD1 in amyotrophic lateral sclerosis. Biochim Biophys Acta (2017) 0.75